S Vavricka - Concepedia

Concepedia

Author

S Vavricka

University Hospital of Zurich

Also Known As

S R Vavricka, S Vavricka, S. R. Vavricka, S. VAVRICKA, S. Vavricka, S.R. Vavricka, SR Vavricka, Stephan R Vavricka, Vavricka, S., Vavricka, S.R.

80

Publications

1.5K

Citations

14

H-Index

13

Concepts

All Affiliations

University Hospital of Zurich Triemli Hospital University Hospital of Lausanne University of Bern University of Zurich

SV

About

S Vavricka is an author at University Hospital of Zurich specializing in autoimmunity, medicine, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	313
2	Allergy	1	1	209
3	Cell Biology	1	1	104
4	Gastroenterology	1	1	209
5	Immunology	1	1	104

S Vavricka

×

15

Publications

1.5K

Citations

14

H-Index

	Year	Citations
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease Torsten Kucharzik, Pierre Ellul, Thomas Greuter, Journal of Crohn s and Colitis	2021	419
The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy Charlotte Hedin, S Vavricka, Andrew J. Stagg, Journal of Crohn s and Colitis InflammationRheumatologyExtraintestinal ManifestationsFunctional Gastrointestinal DisorderAllergy	2018	209
Swallowed topical corticosteroids reduce the risk for long‐lasting bolus impactions in eosinophilic esophagitis Tanja Kuchen, Alex Straumann, Ekaterina Safroneeva, Allergy	2014	128
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease Ekaterina Safroneeva, S Vavricka, Nicolas Fournier, Alimentary Pharmacology & Therapeutics	2015	108
Escalating incidence of eosinophilic esophagitis in <scp>C</scp>anton of <scp>V</scp>aud, <scp>S</scp>witzerland, 1993–2013: a population‐based study B. Giriens, Ping Yan, Ekaterina Safroneeva, Allergy	2015	104
PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis Marianne R. Spalinger, Siegfried Kasper, Christophe Chassard, Mucosal Immunology InflammationIntestinal DysbiosisAutoimmune DiseaseMucosal ImmunologyT-regulatory Cell	2014	104
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce Fernando Magro, J-F Rahier, Cândida Abreu, Journal of Crohn s and Colitis	2020	94
Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells Michael Scharl, Declan F. McCole, Achim Weber, Gut	2010	75
Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy S Vavricka Thorax	2003	72
Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis Anders Eriksson, Anders Kilander, Aldis Puķītis, Alimentary Pharmacology & Therapeutics	2010	34

Page 1